Global Quetiapine Fumarate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 117
Published Date: 02 Jan 2024
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Quetiapine Fumarate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Quetiapine Fumarate API industry chain, the market status of Quetiapine Fumarate Tablets (Purity≥98%, Purity≥99%), Other (Purity≥98%, Purity≥99%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Quetiapine Fumarate API.
Regionally, the report analyzes the Quetiapine Fumarate API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Quetiapine Fumarate API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Quetiapine Fumarate API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Quetiapine Fumarate API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Purity≥98%, Purity≥99%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Quetiapine Fumarate API market.
Regional Analysis: The report involves examining the Quetiapine Fumarate API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Quetiapine Fumarate API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Quetiapine Fumarate API:
Company Analysis: Report covers individual Quetiapine Fumarate API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Quetiapine Fumarate API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Quetiapine Fumarate Tablets, Other).
Technology Analysis: Report covers specific technologies relevant to Quetiapine Fumarate API. It assesses the current state, advancements, and potential future developments in Quetiapine Fumarate API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Quetiapine Fumarate API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Quetiapine Fumarate API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Purity≥98%
Purity≥99%
Market segment by Application
Quetiapine Fumarate Tablets
Other
Major players covered
Dr. Reddy’s
Tapi Teva
Tecoland
Aarti Industries
Hikal
Uquifa
Menadiona
Sumitomo Chemical
Zhejiang Suporpharm
Suanfarma Group
Sibram Pharmaceutical
Hinsun USA
Jubilant Pharma
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quetiapine Fumarate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quetiapine Fumarate API, with price, sales, revenue and global market share of Quetiapine Fumarate API from 2019 to 2024.
Chapter 3, the Quetiapine Fumarate API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quetiapine Fumarate API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Quetiapine Fumarate API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quetiapine Fumarate API.
Chapter 14 and 15, to describe Quetiapine Fumarate API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Quetiapine Fumarate API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quetiapine Fumarate API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Purity≥98%
1.3.3 Purity≥99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Quetiapine Fumarate API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Quetiapine Fumarate Tablets
1.4.3 Other
1.5 Global Quetiapine Fumarate API Market Size & Forecast
1.5.1 Global Quetiapine Fumarate API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Quetiapine Fumarate API Sales Quantity (2019-2030)
1.5.3 Global Quetiapine Fumarate API Average Price (2019-2030)
2.1 Dr. Reddy’s
2.1.1 Dr. Reddy’s Details
2.1.2 Dr. Reddy’s Major Business
2.1.3 Dr. Reddy’s Quetiapine Fumarate API Product and Services
2.1.4 Dr. Reddy’s Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Dr. Reddy’s Recent Developments/Updates
2.2 Tapi Teva
2.2.1 Tapi Teva Details
2.2.2 Tapi Teva Major Business
2.2.3 Tapi Teva Quetiapine Fumarate API Product and Services
2.2.4 Tapi Teva Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Tapi Teva Recent Developments/Updates
2.3 Tecoland
2.3.1 Tecoland Details
2.3.2 Tecoland Major Business
2.3.3 Tecoland Quetiapine Fumarate API Product and Services
2.3.4 Tecoland Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Tecoland Recent Developments/Updates
2.4 Aarti Industries
2.4.1 Aarti Industries Details
2.4.2 Aarti Industries Major Business
2.4.3 Aarti Industries Quetiapine Fumarate API Product and Services
2.4.4 Aarti Industries Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Aarti Industries Recent Developments/Updates
2.5 Hikal
2.5.1 Hikal Details
2.5.2 Hikal Major Business
2.5.3 Hikal Quetiapine Fumarate API Product and Services
2.5.4 Hikal Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hikal Recent Developments/Updates
2.6 Uquifa
2.6.1 Uquifa Details
2.6.2 Uquifa Major Business
2.6.3 Uquifa Quetiapine Fumarate API Product and Services
2.6.4 Uquifa Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Uquifa Recent Developments/Updates
2.7 Menadiona
2.7.1 Menadiona Details
2.7.2 Menadiona Major Business
2.7.3 Menadiona Quetiapine Fumarate API Product and Services
2.7.4 Menadiona Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Menadiona Recent Developments/Updates
2.8 Sumitomo Chemical
2.8.1 Sumitomo Chemical Details
2.8.2 Sumitomo Chemical Major Business
2.8.3 Sumitomo Chemical Quetiapine Fumarate API Product and Services
2.8.4 Sumitomo Chemical Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sumitomo Chemical Recent Developments/Updates
2.9 Zhejiang Suporpharm
2.9.1 Zhejiang Suporpharm Details
2.9.2 Zhejiang Suporpharm Major Business
2.9.3 Zhejiang Suporpharm Quetiapine Fumarate API Product and Services
2.9.4 Zhejiang Suporpharm Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Zhejiang Suporpharm Recent Developments/Updates
2.10 Suanfarma Group
2.10.1 Suanfarma Group Details
2.10.2 Suanfarma Group Major Business
2.10.3 Suanfarma Group Quetiapine Fumarate API Product and Services
2.10.4 Suanfarma Group Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Suanfarma Group Recent Developments/Updates
2.11 Sibram Pharmaceutical
2.11.1 Sibram Pharmaceutical Details
2.11.2 Sibram Pharmaceutical Major Business
2.11.3 Sibram Pharmaceutical Quetiapine Fumarate API Product and Services
2.11.4 Sibram Pharmaceutical Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sibram Pharmaceutical Recent Developments/Updates
2.12 Hinsun USA
2.12.1 Hinsun USA Details
2.12.2 Hinsun USA Major Business
2.12.3 Hinsun USA Quetiapine Fumarate API Product and Services
2.12.4 Hinsun USA Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Hinsun USA Recent Developments/Updates
2.13 Jubilant Pharma
2.13.1 Jubilant Pharma Details
2.13.2 Jubilant Pharma Major Business
2.13.3 Jubilant Pharma Quetiapine Fumarate API Product and Services
2.13.4 Jubilant Pharma Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Jubilant Pharma Recent Developments/Updates
2.14 Qilu Pharmaceutical
2.14.1 Qilu Pharmaceutical Details
2.14.2 Qilu Pharmaceutical Major Business
2.14.3 Qilu Pharmaceutical Quetiapine Fumarate API Product and Services
2.14.4 Qilu Pharmaceutical Quetiapine Fumarate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Qilu Pharmaceutical Recent Developments/Updates
3.1 Global Quetiapine Fumarate API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Quetiapine Fumarate API Revenue by Manufacturer (2019-2024)
3.3 Global Quetiapine Fumarate API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Quetiapine Fumarate API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Quetiapine Fumarate API Manufacturer Market Share in 2023
3.4.2 Top 6 Quetiapine Fumarate API Manufacturer Market Share in 2023
3.5 Quetiapine Fumarate API Market: Overall Company Footprint Analysis
3.5.1 Quetiapine Fumarate API Market: Region Footprint
3.5.2 Quetiapine Fumarate API Market: Company Product Type Footprint
3.5.3 Quetiapine Fumarate API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Quetiapine Fumarate API Market Size by Region
4.1.1 Global Quetiapine Fumarate API Sales Quantity by Region (2019-2030)
4.1.2 Global Quetiapine Fumarate API Consumption Value by Region (2019-2030)
4.1.3 Global Quetiapine Fumarate API Average Price by Region (2019-2030)
4.2 North America Quetiapine Fumarate API Consumption Value (2019-2030)
4.3 Europe Quetiapine Fumarate API Consumption Value (2019-2030)
4.4 Asia-Pacific Quetiapine Fumarate API Consumption Value (2019-2030)
4.5 South America Quetiapine Fumarate API Consumption Value (2019-2030)
4.6 Middle East and Africa Quetiapine Fumarate API Consumption Value (2019-2030)
5.1 Global Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
5.2 Global Quetiapine Fumarate API Consumption Value by Type (2019-2030)
5.3 Global Quetiapine Fumarate API Average Price by Type (2019-2030)
6.1 Global Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
6.2 Global Quetiapine Fumarate API Consumption Value by Application (2019-2030)
6.3 Global Quetiapine Fumarate API Average Price by Application (2019-2030)
7.1 North America Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
7.2 North America Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
7.3 North America Quetiapine Fumarate API Market Size by Country
7.3.1 North America Quetiapine Fumarate API Sales Quantity by Country (2019-2030)
7.3.2 North America Quetiapine Fumarate API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
8.2 Europe Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
8.3 Europe Quetiapine Fumarate API Market Size by Country
8.3.1 Europe Quetiapine Fumarate API Sales Quantity by Country (2019-2030)
8.3.2 Europe Quetiapine Fumarate API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Quetiapine Fumarate API Market Size by Region
9.3.1 Asia-Pacific Quetiapine Fumarate API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Quetiapine Fumarate API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
10.2 South America Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
10.3 South America Quetiapine Fumarate API Market Size by Country
10.3.1 South America Quetiapine Fumarate API Sales Quantity by Country (2019-2030)
10.3.2 South America Quetiapine Fumarate API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Quetiapine Fumarate API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Quetiapine Fumarate API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Quetiapine Fumarate API Market Size by Country
11.3.1 Middle East & Africa Quetiapine Fumarate API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Quetiapine Fumarate API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Quetiapine Fumarate API Market Drivers
12.2 Quetiapine Fumarate API Market Restraints
12.3 Quetiapine Fumarate API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Quetiapine Fumarate API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quetiapine Fumarate API
13.3 Quetiapine Fumarate API Production Process
13.4 Quetiapine Fumarate API Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quetiapine Fumarate API Typical Distributors
14.3 Quetiapine Fumarate API Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Quetiapine Fumarate API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Quetiapine Fumarate API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Dr. Reddy’s Basic Information, Manufacturing Base and Competitors
Table 4. Dr. Reddy’s Major Business
Table 5. Dr. Reddy’s Quetiapine Fumarate API Product and Services
Table 6. Dr. Reddy’s Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Dr. Reddy’s Recent Developments/Updates
Table 8. Tapi Teva Basic Information, Manufacturing Base and Competitors
Table 9. Tapi Teva Major Business
Table 10. Tapi Teva Quetiapine Fumarate API Product and Services
Table 11. Tapi Teva Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Tapi Teva Recent Developments/Updates
Table 13. Tecoland Basic Information, Manufacturing Base and Competitors
Table 14. Tecoland Major Business
Table 15. Tecoland Quetiapine Fumarate API Product and Services
Table 16. Tecoland Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Tecoland Recent Developments/Updates
Table 18. Aarti Industries Basic Information, Manufacturing Base and Competitors
Table 19. Aarti Industries Major Business
Table 20. Aarti Industries Quetiapine Fumarate API Product and Services
Table 21. Aarti Industries Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Aarti Industries Recent Developments/Updates
Table 23. Hikal Basic Information, Manufacturing Base and Competitors
Table 24. Hikal Major Business
Table 25. Hikal Quetiapine Fumarate API Product and Services
Table 26. Hikal Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hikal Recent Developments/Updates
Table 28. Uquifa Basic Information, Manufacturing Base and Competitors
Table 29. Uquifa Major Business
Table 30. Uquifa Quetiapine Fumarate API Product and Services
Table 31. Uquifa Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Uquifa Recent Developments/Updates
Table 33. Menadiona Basic Information, Manufacturing Base and Competitors
Table 34. Menadiona Major Business
Table 35. Menadiona Quetiapine Fumarate API Product and Services
Table 36. Menadiona Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Menadiona Recent Developments/Updates
Table 38. Sumitomo Chemical Basic Information, Manufacturing Base and Competitors
Table 39. Sumitomo Chemical Major Business
Table 40. Sumitomo Chemical Quetiapine Fumarate API Product and Services
Table 41. Sumitomo Chemical Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sumitomo Chemical Recent Developments/Updates
Table 43. Zhejiang Suporpharm Basic Information, Manufacturing Base and Competitors
Table 44. Zhejiang Suporpharm Major Business
Table 45. Zhejiang Suporpharm Quetiapine Fumarate API Product and Services
Table 46. Zhejiang Suporpharm Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Zhejiang Suporpharm Recent Developments/Updates
Table 48. Suanfarma Group Basic Information, Manufacturing Base and Competitors
Table 49. Suanfarma Group Major Business
Table 50. Suanfarma Group Quetiapine Fumarate API Product and Services
Table 51. Suanfarma Group Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Suanfarma Group Recent Developments/Updates
Table 53. Sibram Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Sibram Pharmaceutical Major Business
Table 55. Sibram Pharmaceutical Quetiapine Fumarate API Product and Services
Table 56. Sibram Pharmaceutical Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Sibram Pharmaceutical Recent Developments/Updates
Table 58. Hinsun USA Basic Information, Manufacturing Base and Competitors
Table 59. Hinsun USA Major Business
Table 60. Hinsun USA Quetiapine Fumarate API Product and Services
Table 61. Hinsun USA Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Hinsun USA Recent Developments/Updates
Table 63. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Jubilant Pharma Major Business
Table 65. Jubilant Pharma Quetiapine Fumarate API Product and Services
Table 66. Jubilant Pharma Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Jubilant Pharma Recent Developments/Updates
Table 68. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Qilu Pharmaceutical Major Business
Table 70. Qilu Pharmaceutical Quetiapine Fumarate API Product and Services
Table 71. Qilu Pharmaceutical Quetiapine Fumarate API Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Qilu Pharmaceutical Recent Developments/Updates
Table 73. Global Quetiapine Fumarate API Sales Quantity by Manufacturer (2019-2024) & (MT)
Table 74. Global Quetiapine Fumarate API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Quetiapine Fumarate API Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 76. Market Position of Manufacturers in Quetiapine Fumarate API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Quetiapine Fumarate API Production Site of Key Manufacturer
Table 78. Quetiapine Fumarate API Market: Company Product Type Footprint
Table 79. Quetiapine Fumarate API Market: Company Product Application Footprint
Table 80. Quetiapine Fumarate API New Market Entrants and Barriers to Market Entry
Table 81. Quetiapine Fumarate API Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Quetiapine Fumarate API Sales Quantity by Region (2019-2024) & (MT)
Table 83. Global Quetiapine Fumarate API Sales Quantity by Region (2025-2030) & (MT)
Table 84. Global Quetiapine Fumarate API Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Quetiapine Fumarate API Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Quetiapine Fumarate API Average Price by Region (2019-2024) & (USD/Kg)
Table 87. Global Quetiapine Fumarate API Average Price by Region (2025-2030) & (USD/Kg)
Table 88. Global Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 89. Global Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 90. Global Quetiapine Fumarate API Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Quetiapine Fumarate API Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Quetiapine Fumarate API Average Price by Type (2019-2024) & (USD/Kg)
Table 93. Global Quetiapine Fumarate API Average Price by Type (2025-2030) & (USD/Kg)
Table 94. Global Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 95. Global Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 96. Global Quetiapine Fumarate API Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Quetiapine Fumarate API Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Quetiapine Fumarate API Average Price by Application (2019-2024) & (USD/Kg)
Table 99. Global Quetiapine Fumarate API Average Price by Application (2025-2030) & (USD/Kg)
Table 100. North America Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 101. North America Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 102. North America Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 103. North America Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 104. North America Quetiapine Fumarate API Sales Quantity by Country (2019-2024) & (MT)
Table 105. North America Quetiapine Fumarate API Sales Quantity by Country (2025-2030) & (MT)
Table 106. North America Quetiapine Fumarate API Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Quetiapine Fumarate API Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 109. Europe Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 110. Europe Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 111. Europe Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 112. Europe Quetiapine Fumarate API Sales Quantity by Country (2019-2024) & (MT)
Table 113. Europe Quetiapine Fumarate API Sales Quantity by Country (2025-2030) & (MT)
Table 114. Europe Quetiapine Fumarate API Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Quetiapine Fumarate API Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 117. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 118. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 119. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 120. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Region (2019-2024) & (MT)
Table 121. Asia-Pacific Quetiapine Fumarate API Sales Quantity by Region (2025-2030) & (MT)
Table 122. Asia-Pacific Quetiapine Fumarate API Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Quetiapine Fumarate API Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 125. South America Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 126. South America Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 127. South America Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 128. South America Quetiapine Fumarate API Sales Quantity by Country (2019-2024) & (MT)
Table 129. South America Quetiapine Fumarate API Sales Quantity by Country (2025-2030) & (MT)
Table 130. South America Quetiapine Fumarate API Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Quetiapine Fumarate API Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Type (2019-2024) & (MT)
Table 133. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Type (2025-2030) & (MT)
Table 134. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Application (2019-2024) & (MT)
Table 135. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Application (2025-2030) & (MT)
Table 136. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Region (2019-2024) & (MT)
Table 137. Middle East & Africa Quetiapine Fumarate API Sales Quantity by Region (2025-2030) & (MT)
Table 138. Middle East & Africa Quetiapine Fumarate API Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Quetiapine Fumarate API Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Quetiapine Fumarate API Raw Material
Table 141. Key Manufacturers of Quetiapine Fumarate API Raw Materials
Table 142. Quetiapine Fumarate API Typical Distributors
Table 143. Quetiapine Fumarate API Typical Customers
List of Figures
Figure 1. Quetiapine Fumarate API Picture
Figure 2. Global Quetiapine Fumarate API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Quetiapine Fumarate API Consumption Value Market Share by Type in 2023
Figure 4. Purity≥98% Examples
Figure 5. Purity≥99% Examples
Figure 6. Global Quetiapine Fumarate API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Quetiapine Fumarate API Consumption Value Market Share by Application in 2023
Figure 8. Quetiapine Fumarate Tablets Examples
Figure 9. Other Examples
Figure 10. Global Quetiapine Fumarate API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Quetiapine Fumarate API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Quetiapine Fumarate API Sales Quantity (2019-2030) & (MT)
Figure 13. Global Quetiapine Fumarate API Average Price (2019-2030) & (USD/Kg)
Figure 14. Global Quetiapine Fumarate API Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Quetiapine Fumarate API Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Quetiapine Fumarate API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Quetiapine Fumarate API Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Quetiapine Fumarate API Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Quetiapine Fumarate API Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Quetiapine Fumarate API Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Quetiapine Fumarate API Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Quetiapine Fumarate API Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Quetiapine Fumarate API Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Quetiapine Fumarate API Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Quetiapine Fumarate API Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Quetiapine Fumarate API Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Quetiapine Fumarate API Average Price by Type (2019-2030) & (USD/Kg)
Figure 29. Global Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Quetiapine Fumarate API Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Quetiapine Fumarate API Average Price by Application (2019-2030) & (USD/Kg)
Figure 32. North America Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Quetiapine Fumarate API Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Quetiapine Fumarate API Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Quetiapine Fumarate API Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Quetiapine Fumarate API Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Quetiapine Fumarate API Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Quetiapine Fumarate API Consumption Value Market Share by Region (2019-2030)
Figure 52. China Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Quetiapine Fumarate API Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Quetiapine Fumarate API Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Quetiapine Fumarate API Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Quetiapine Fumarate API Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Quetiapine Fumarate API Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Quetiapine Fumarate API Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Quetiapine Fumarate API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Quetiapine Fumarate API Market Drivers
Figure 73. Quetiapine Fumarate API Market Restraints
Figure 74. Quetiapine Fumarate API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Quetiapine Fumarate API in 2023
Figure 77. Manufacturing Process Analysis of Quetiapine Fumarate API
Figure 78. Quetiapine Fumarate API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Dr. Reddy’s Tapi Teva Tecoland Aarti Industries Hikal Uquifa Menadiona Sumitomo Chemical Zhejiang Suporpharm Suanfarma Group Sibram Pharmaceutical Hinsun USA Jubilant Pharma Qilu Pharmaceutical
Related Reports
14 Mar 2023
Chemical & Material
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
